Immunotherapy of malignant melanoma.
D000912:Antibodies, Neoplasm / Q000276:immunology; D000951:Antigens, Neoplasm / Q000276:immunology; D001500:BCG Vaccine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005500:Follow-Up Studies; D006801:Humans; D007167:Immunotherapy; D007978:Levamisole / Q000627:therapeutic use; D008207:Lymphatic Metastasis; D008545:Melanoma / Q000601:surgery / Q000628:therapy*; D009369:Neoplasms / Q000276:immunology / Q000628:therapy; D011897:Random Allocation
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D007978:Levamisole